Additionally, downregulation of PHLDA1 caused a significant decrease in the cell cycle inhibitor, CDKN1A (P21) and an increase in expression of TRKB that are among other markers of poor prognosis in neuroblastoma. The gene discussed is PHLDA1; the disease is neuroblastoma.